Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Doximity (DOCS) Capital Expenditures (2020 - 2025)

Doximity (DOCS) has disclosed Capital Expenditures for 6 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 30.6% to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.2 million, a 62.51% increase, with the full-year FY2025 number at $6.5 million, up 4338.78% from a year prior.
  • Capital Expenditures was $2.3 million for Q4 2025 at Doximity, down from $2.4 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.5 million in Q4 2021 to a low of -$3.4 million in Q1 2021.
  • A 5-year average of $813263.2 and a median of $1.5 million in 2023 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: tumbled 269.4% in 2023, then skyrocketed 4819.44% in 2024.
  • Doximity's Capital Expenditures stood at $2.5 million in 2021, then tumbled by 59.44% to $1.0 million in 2022, then plummeted by 96.44% to $36000.0 in 2023, then surged by 4819.44% to $1.8 million in 2024, then soared by 30.6% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for DOCS's Capital Expenditures are $2.3 million (Q4 2025), $2.4 million (Q3 2025), and $2.0 million (Q2 2025).